Bibliographic information
GuidelineMedical eligibility criteria for contraceptive use, 6th ed.
Year of Publication2025
Issuing InstitutionWorld Health Organization
Recommendation
Updated
Women living with severe or advanced HIV clinical disease (WHO stage 3 or 4) who are using protease inhibitors should generally not initiate use of the levonorgestrel-releasing intrauterine device (LNG-IUD)
Certainty of evidence
Very low
Notes and Remarks
There is no known interaction between ART and IUD use